raremaprare-disease reference indexOrphadata 2026-06-23 · HPO 2026-09-01
ORPHA:477774

Combined oxidative phosphorylation defect type 27

Synonyms: COXPD27

Type
Disease
Group
Disorder
Inheritance
Autosomal recessive
Age of onset
Childhood, Infancy
Status
active

A rare mitochondrial oxidative phosphorylation disorder characterized by a variable clinical phenotype including infantile onset of epileptic encephalopathy, hypotonia, global developmental delay, failure to thrive, complex movement disorder, and liver involvement, as well as childhood onset of severe myoclonus epilepsy, cognitive decline, progressive hearing and visual impairment, and progressive tetraparesis. Serum lactate may be increased, and brain imaging shows variable atrophy and white matter abnormalities.

1

Names in Orphadata languages

12 of 12 languages
LangNameSynonyms
enCombined oxidative phosphorylation defect type 27COXPD27
frDéficit combiné de la phosphorylation oxydative type 27= en
deKombinierter Defekt der oxidativen Phosphorylierung Typ 27= en
esDeficiencia combinada de la fosforilación oxidativa tipo 27= en
itDifetto combinato della fosforilazione ossidativa tipo 27
nlGecombineerde oxidatieve fosforylatiedeficiëntie type 27COXPD27 · Gecombineerde oxidatieve fosforyleringdeficiëntie type 27
ptDéfice combinado da fosforilação oxidativa tipo 27
plZłożony defekt fosforylacji oksydacyjnej typu 27= en
csKombinovaný defekt oxidativní fosforylace, typ 27= en
ukКомбінований дефект окисного фосфорилювання, тип 27= en
zh复合氧化磷酸化缺陷27型= en
trKombine oksidatif fosforilasyon defekti tip 27= en

Definition in:

2

Cross-references

qualifier = Orphanet mapping relation
SourceCodeQualifierICD relationValidation
OMIM616672Evalidated
ICD-10E88.8NTBTattributedvalidated
ICD-115C53.23NTBTattributedvalidated
MONDO0014728Evalidated
UMLSC5567608Evalidated

E exact · NTBT this ORPHAcode is narrower than the target · BTNT broader than the target · ND not decided.

3

Classification

Preferential parent (Orphanet linearisation):

Parents in the classifications (3):

No children.

4

Genes

1 direct
GeneAssociationStatusHGNCEnsemblOMIMLocusNameSource of validation
CARS2Disease-causing germline mutation(s) inAssessedHGNC:25695ENSG0000013490561280013q34cysteinyl-tRNA synthetase 2, mitochondrial25787132[PMID]_25361775[PMID]
5

Prevalence and incidence

2 records
TypeClassValueAreaQualificationValidationSource
Cases/families3 casesWorldwideCase(s)Validated25361775[PMID]_25787132[PMID]
Point prevalence<1 / 1 000 000—WorldwideClass onlyValidatedORPHANET_25361775[PMID]_25787132[PMID]

Value is Orphadata's ValMoy: the mean estimate per 100 000 for prevalence and incidence, the number of cases or families for case reports.

6

HPO phenotypes

29 annotations · validated 2019-09-27
HPOTerm (as annotated by Orphanet)Diagnostic
Frequent (79-30%)
HP:0002500Abnormal cerebral white matter morphology
HP:0011923Decreased activity of mitochondrial complex I
HP:0011924Decreased activity of mitochondrial complex III
HP:0008347Decreased activity of mitochondrial complex IV
HP:0002376Developmental regression
HP:0002506Diffuse cerebral atrophy
HP:0200134Epileptic encephalopathy
HP:0002123Generalized myoclonic seizure
HP:0001263Global developmental delay
HP:0000365Hearing impairment
HP:0002151Increased circulating lactate concentration
HP:0001249Intellectual disability
HP:0031165Multifocal seizures
HP:0000529Progressive visual loss
HP:0003200Ragged-red muscle fibers
HP:0002133Status epilepticus
HP:0002273Tetraparesis
Occasional (29-5%)
HP:0001344Absent speech
HP:0000729Autistic behavior
HP:0100275Diffuse cerebellar atrophy
HP:0002015Dysphagia
HP:0010853EEG with periodic lateralized epileptiform discharges
HP:0002079Hypoplasia of the corpus callosum
HP:0025517Hypoplastic hippocampus
HP:0004305Involuntary movements
HP:0040288Nasogastric tube feeding
HP:0001790Nonimmune hydrops fetalis
HP:0012531Pain
HP:0007351Upper limb postural tremor

Annotation source: 30139652[PMID]_25787132[PMID]_25361775[PMID]

7

Sources for this card